- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0011293

About Hahnemann Pharmaceuticals Private Limited
Data last updated:
Hahnemann Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 14 July 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1996PTC080135. Its GSTIN is 07AAACH1772R1Z5 (Delhi).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹4.92 Lakh. It is led by directors including Neeru Narula and Pooja Narula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 7 Naraina Industrial Area Phase – I, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2024, the company reported a revenue of ₹70.46 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹37,249 (net margin 0.5%) and EBITDA of ₹3.62 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹83 Lakh on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.
Hahnemann Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0011293). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hahnemannpharma.com.
Company details
Recognitions & Rankings of Hahnemann Pharmaceuticals
Contact details
Hahnemann Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is hahnemannpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressA – 7 Naraina Industrial Area Phase – I, New Delhi, Delhi, India – 110028
- IndustryHealthcare, Alternative & Holistic Medicine
To see the full contact details of Hahnemann Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hahnemann Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Financials of Hahnemann Pharmaceuticals Private Limited
FY 2025 filings availableHahnemann Pharmaceuticals Private Limited reported revenue of ₹70.46 Lakh (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 28% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37,249 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hahnemann Pharmaceuticals Private Limited
Hahnemann Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeru Narula | Director | 14 Jul 1996 | 30 Years 3 Months | Current |
| Karan Narula | Additional Director | 02 Sep 2019 | 7 Years 2 Months | Current |
| Pooja Narula | Director | 14 Jul 1996 | 30 Years 3 Months | Current |
Peer comparison
Hahnemann Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vizag Pharmaceuticals Private Limited | ₹70.81 Lakh (FY 2016) | -52.0% | Hyderabad, Telangana, India | |||
| Ecstatic Pharmaceuticals Private Limited | ₹70.76 Lakh (FY 2023) | 13.0% | Thane, Maharashtra, India | |||
| Physa Pharmaceuticals Private Limited | ₹70.69 Lakh (FY 2025) | 8.0% | Noida, Uttar Pradesh, India | |||
| Hahnemann Pharmaceuticals Private Limitedthis company | ₹70.46 Lakh (FY 2024) | ₹37,249 | 0.5% | 28.0% | New Delhi, Delhi, India | |
| Cross Berry Pharmaceuticals Private Limited | ₹69.6 Lakh (FY 2020) | 50.0% | Kolhapur, Maharashtra, India | |||
| Deemar Pharmaceuticals Private Limited | ₹69.5 Lakh (FY 2025) | 46233.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Auditor
Hahnemann Pharmaceuticals Private Limited is audited by R. Chadha & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. Chadha & Associates | FY 2017 | 83135 |
Shareholding
The shareholding of Hahnemann Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2005 | 90059013 | Bank of India | ₹53 Lakh | Open | |
| 20 Dec 2002 | 90057944 | The Jammu & Kashmir Bank Ltd. | ₹16 Lakh | Open | |
| 06 Jan 2000 | 90057164 | Uco Bank | ₹5 Lakh | Open | |
| 11 Sep 1997 | 90056749 | Union Bank of India | ₹9 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
Hahnemann Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Hahnemann Pharmaceuticals, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Execution petition | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
| District court, North East, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
To see the full case history of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hahnemann Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hahnemann Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACH1772R1Z5 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hahnemann Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hahnemann Pharmaceuticals Private Limited has 3 board changes on record since 1996: 3 appointments. The latest: Karan Narula was appointed as Additional Director on 02 Sep 2019.
Frequently asked questions
Hahnemann Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 14 July 1996 (30+ years old) and is registered under CIN U24232DL1996PTC080135.
Hahnemann Pharmaceuticals has 3 current directors:
- Neeru Narula - Director
- Karan Narula - Additional Director
- Pooja Narula - Director
The latest financial statements of Hahnemann Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hahnemann Pharmaceuticals is 07AAACH1772R1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Hahnemann Pharmaceuticals is U24232DL1996PTC080135. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hahnemann Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.
Hahnemann Pharmaceuticals was incorporated on 14 July 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Hahnemann Pharmaceuticals by revenue are Vizag Pharmaceuticals Private Limited, Ecstatic Pharmaceuticals Private Limited, Physa Pharmaceuticals Private Limited, Cross Berry Pharmaceuticals Private Limited, Deemar Pharmaceuticals Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Karan Narula was appointed as Additional Director on 02 Sep 2019. Neeru Narula was appointed as Director on 14 Jul 1996. Pooja Narula was appointed as Director on 14 Jul 1996.
Yes, Hahnemann Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0011293).
Hahnemann Pharmaceuticals can be reached through the website hahnemannpharma.com. Its registered office is in New Delhi, Delhi, India.

